Please enable JavaScript to continue using this application.

Compare $CNXU vs $IMDX | Chartloom

Compare

$CNXU vs $IMDX

Conexeu Sciences Inc · Insight Molecular Diagnostics Inc

CNXU

Conexeu Sciences Inc

IMDX

Insight Molecular Diagnostics Inc

Compare $CNXU vs $IMDX

Comparing Conexeu Sciences Inc and Insight Molecular Diagnostics Inc

CNXUConexeu Sciences Inc

IMDXInsight Molecular Diagnostics Inc

CNXUConexeu Sciences Inc

Market cap

$104M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.2%

52W performance

-70.2%

FCF yield

-11.4%

IMDXInsight Molecular Diagnostics Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

58.81x

Rev growth (TTM)

-60.8%

YTD performance

-52.9%

52W performance

-8.4%

FCF yield

-28.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNXU

IMDX

Detailed metrics comparison

CNXU

Conexeu Sciences Inc

IMDX

Insight Molecular Diagnostics Inc

Market Cap

CNXU$104M

IMDX$109M

Enterprise Value

CNXU$102M

IMDX$92M

Price

CNXU$3.89

IMDX$3.37

P/E Ratio

CNXUN/A

IMDXN/A

P/S Ratio

CNXU0.00x

IMDX65.16x

EV/Sales

CNXU0.00x

IMDX54.99x

EV/EBITDA

CNXU0.00x

IMDX0.00x

P/B Ratio

CNXU14.95x

IMDX102.52x

P/FCF Ratio

CNXUN/A

IMDXN/A

EV/FCF

CNXU-8.61x

IMDX-2.97x

PEG Ratio

CNXUN/A

IMDXN/A

Forward P/E (NTM)

CNXUN/A

IMDXN/A

Forward P/S (NTM)

CNXUN/A

IMDX58.81x

Revenue (TTM)

CNXU$0

IMDX$2M

Revenue Growth (YoY)

CNXUN/A

IMDX-60.8%

Forward Rev Growth

CNXU88.8%

IMDX593.7%

Gross Margin (TTM)

CNXU0.0%

IMDX48.3%

Operating Margin (TTM)

CNXU0.0%

IMDX0.0%

EBITDA Margin (TTM)

CNXU0.0%

IMDX-1986.2%

Net Margin (TTM)

CNXU0.0%

IMDX-2955.6%

FCF Margin (TTM)

CNXUN/A

IMDX-1848.8%

Net Income (TTM)

CNXU$-16M

IMDX$-49M

FCF (TTM)

CNXU$-12M

IMDX$-31M

EPS (TTM)

CNXU-$0.58

IMDX-$1.34

ROE (TTM)

CNXU-23026.0%

IMDX-42668.0%

ROA (TTM)

CNXU-20389.0%

IMDX-14147.0%

ROIC (TTM)

CNXU-23026.0%

IMDX-37415.0%

Cash

CNXU$2M

IMDX$18M

Debt

CNXU$0

IMDX$766K

Net Cash/Debt

CNXU$2M

IMDX$17M

Current Ratio (TTM)

CNXU5.31x

IMDX2.00x

Quick Ratio (TTM)

CNXU1.74x

IMDX1.82x

Debt/Equity (TTM)

CNXU0.00x

IMDX0.92x

Debt/Assets (TTM)

CNXU0.0%

IMDX0.0%

Interest Coverage (TTM)

CNXUN/A

IMDXN/A

Net Debt/EBITDA (TTM)

CNXU0.00x

IMDX0.00x

Beta

CNXU-2.20

IMDX1.86

52W Performance

CNXU-70.2%

IMDX-8.4%

YTD Performance

CNXU-70.2%

IMDX-52.9%

% from 52W High

CNXU-79.3%

IMDX-60.4%

% from 52W Low

CNXU27.5%

IMDX39.3%

Asset Turnover (TTM)

CNXU0.00x

IMDX0.05x

FCF Yield (TTM)

CNXU-11.4%

IMDX-28.4%

Earnings Yield (TTM)

CNXU-15.1%

IMDX-45.4%

Dividend Yield (TTM)

CNXUN/A

IMDXN/A

Rule of 40

CNXU0.0

IMDX-1,909.6

EV/GP/RG

CNXUN/A

IMDX10.54

Ticker research

View CNXU research View IMDX research

Metric	CNXU Conexeu Sciences Inc	IMDX Insight Molecular Diagnostics Inc
Market & Valuation
Market Cap	$104M	$109M
Enterprise Value	$102M	$92M
Price	$3.89	$3.37
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	65.16x
EV/Sales	0.00x	54.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.95x	102.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.61x	-2.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	58.81x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-60.8%
Forward Rev Growth	88.8%	593.7%
Profitability
Gross Margin (TTM)	0.0%	48.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1986.2%
Net Margin (TTM)	0.0%	-2955.6%
FCF Margin (TTM)	N/A	-1848.8%
Net Income (TTM)	$-16M	$-49M
FCF (TTM)	$-12M	$-31M
EPS (TTM)	-$0.58	-$1.34
ROE (TTM)	-23026.0%	-42668.0%
ROA (TTM)	-20389.0%	-14147.0%
ROIC (TTM)	-23026.0%	-37415.0%
Financial Health
Cash	$2M	$18M
Debt	$0	$766K
Net Cash/Debt	$2M	$17M
Current Ratio (TTM)	5.31x	2.00x
Quick Ratio (TTM)	1.74x	1.82x
Debt/Equity (TTM)	0.00x	0.92x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.20	1.86
52W Performance	-70.2%	-8.4%
YTD Performance	-70.2%	-52.9%
% from 52W High	-79.3%	-60.4%
% from 52W Low	27.5%	39.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-11.4%	-28.4%
Earnings Yield (TTM)	-15.1%	-45.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,909.6
EV/GP/RG	N/A	10.54
Ticker research	View CNXU research	View IMDX research

Valuation

P/S Ratio

CNXU

0.00x

IMDX

65.16x

EV/FCF

CNXU

-8.61x

IMDX

-2.97x

Growth & revenue

Revenue Growth TTM

IMDX

-60.8%

Forward Revenue Growth

IMDX

593.7%

CNXU

88.8%

Profitability & performance

Gross Margin

IMDX

48.3%

CNXU

0.0%

ROE

CNXU

-23026.0%

IMDX

-42668.0%

FCF Yield %

CNXU

-11.4%

IMDX

-28.4%

52-Week Performance

IMDX

-8.4%

CNXU

-70.2%

Detailed metrics comparison

CNXU

Conexeu Sciences Inc

IMDX

Insight Molecular Diagnostics Inc

Market Cap

CNXU$104M

IMDX$109M

Enterprise Value

CNXU$102M

IMDX$92M

Price

CNXU$3.89

IMDX$3.37

P/E Ratio

CNXUN/A

IMDXN/A

P/S Ratio

CNXU0.00x

IMDX65.16x

EV/Sales

CNXU0.00x

IMDX54.99x

EV/EBITDA

CNXU0.00x

IMDX0.00x

P/B Ratio

CNXU14.95x

IMDX102.52x

P/FCF Ratio

CNXUN/A

IMDXN/A

EV/FCF

CNXU-8.61x

IMDX-2.97x

PEG Ratio

CNXUN/A

IMDXN/A

Forward P/E (NTM)

CNXUN/A

IMDXN/A

Forward P/S (NTM)

CNXUN/A

IMDX58.81x

Revenue (TTM)

CNXU$0

IMDX$2M

Revenue Growth (YoY)

CNXUN/A

IMDX-60.8%

Forward Rev Growth

CNXU88.8%

IMDX593.7%

Gross Margin (TTM)

CNXU0.0%

IMDX48.3%

Operating Margin (TTM)

CNXU0.0%

IMDX0.0%

EBITDA Margin (TTM)

CNXU0.0%

IMDX-1986.2%

Net Margin (TTM)

CNXU0.0%

IMDX-2955.6%

FCF Margin (TTM)

CNXUN/A

IMDX-1848.8%

Net Income (TTM)

CNXU$-16M

IMDX$-49M

FCF (TTM)

CNXU$-12M

IMDX$-31M

EPS (TTM)

CNXU-$0.58

IMDX-$1.34

ROE (TTM)

CNXU-23026.0%

IMDX-42668.0%

ROA (TTM)

CNXU-20389.0%

IMDX-14147.0%

ROIC (TTM)

CNXU-23026.0%

IMDX-37415.0%

Cash

CNXU$2M

IMDX$18M

Debt

CNXU$0

IMDX$766K

Net Cash/Debt

CNXU$2M

IMDX$17M

Current Ratio (TTM)

CNXU5.31x

IMDX2.00x

Quick Ratio (TTM)

CNXU1.74x

IMDX1.82x

Debt/Equity (TTM)

CNXU0.00x

IMDX0.92x

Debt/Assets (TTM)

CNXU0.0%

IMDX0.0%

Interest Coverage (TTM)

CNXUN/A

IMDXN/A

Net Debt/EBITDA (TTM)

CNXU0.00x

IMDX0.00x

Beta

CNXU-2.20

IMDX1.86

52W Performance

CNXU-70.2%

IMDX-8.4%

YTD Performance

CNXU-70.2%

IMDX-52.9%

% from 52W High

CNXU-79.3%

IMDX-60.4%

% from 52W Low

CNXU27.5%

IMDX39.3%

Asset Turnover (TTM)

CNXU0.00x

IMDX0.05x

FCF Yield (TTM)

CNXU-11.4%

IMDX-28.4%

Earnings Yield (TTM)

CNXU-15.1%

IMDX-45.4%

Dividend Yield (TTM)

CNXUN/A

IMDXN/A

Rule of 40

CNXU0.0

IMDX-1,909.6

EV/GP/RG

CNXUN/A

IMDX10.54

Ticker research

View CNXU research View IMDX research

Metric	CNXU Conexeu Sciences Inc	IMDX Insight Molecular Diagnostics Inc
Market & Valuation
Market Cap	$104M	$109M
Enterprise Value	$102M	$92M
Price	$3.89	$3.37
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	65.16x
EV/Sales	0.00x	54.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.95x	102.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.61x	-2.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	58.81x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-60.8%
Forward Rev Growth	88.8%	593.7%
Profitability
Gross Margin (TTM)	0.0%	48.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1986.2%
Net Margin (TTM)	0.0%	-2955.6%
FCF Margin (TTM)	N/A	-1848.8%
Net Income (TTM)	$-16M	$-49M
FCF (TTM)	$-12M	$-31M
EPS (TTM)	-$0.58	-$1.34
ROE (TTM)	-23026.0%	-42668.0%
ROA (TTM)	-20389.0%	-14147.0%
ROIC (TTM)	-23026.0%	-37415.0%
Financial Health
Cash	$2M	$18M
Debt	$0	$766K
Net Cash/Debt	$2M	$17M
Current Ratio (TTM)	5.31x	2.00x
Quick Ratio (TTM)	1.74x	1.82x
Debt/Equity (TTM)	0.00x	0.92x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.20	1.86
52W Performance	-70.2%	-8.4%
YTD Performance	-70.2%	-52.9%
% from 52W High	-79.3%	-60.4%
% from 52W Low	27.5%	39.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-11.4%	-28.4%
Earnings Yield (TTM)	-15.1%	-45.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,909.6
EV/GP/RG	N/A	10.54
Ticker research	View CNXU research	View IMDX research